![]() ![]() | Free Sperm Donor - Northern California / San Francisco Bay Area |
Sexually Transmitted Diseases (STD) Tests Copies
For the STD testing policy & procedures, see http://trentdonor.org/std-policy
For the lifestyle questionnaire, see http://trentdonor.org/screening
Below are Trent's lab results to STD testing which can be reviewed by a recipient's physician:
Most recent 2010 STD results and physical exam (click for copy):
| Page 1: | Page 2: | Physical Exam |
![]() |
![]() |
![]() |
For an easy to read PDF file of the above lab results suitable for printing, click here:
trentdonor-std-result-final-viromed-fda-guidance-2010.pdf
Below are Trent's results to STD testing in web format which can be reviewed by a recipient's physician:
| Test | Common Name | Date of Last Test (click for copy) | Trent's Result (copied from lab paperwork) | Prevalence in general population |
| HIV-1 Antibody (Groups M+O) Enzyme Immunoassay (EIA) test and HIV-1 Nucleic Acid-based test (NAT) (donor tests) | AIDS | Jul, 2010 | Non Reactive | 0.6% |
| HIV-2 Antibody Enzyme Immunoassay (EIA) test (donor test) | AIDS (west African) | Jul, 2010 | Negative | 0% (USA) |
| Chlamydia Trachomatis Nucleic Acid Amplification from urine (NAA) | Chlamydia | Jul, 2010 | Negative | 1.4% |
| Neisseria Gonorrhoeae Nucleic Acid Amplification from urine (NAA) | Gonorrhea, CLAP | Jul, 2010 | Negative | 0.29% |
| Hepatitis A IgM Antibody | Hepatitis A, HAV | Jan, 2009 | Negative | 38% (antibodies) |
| Hepatitis B Surface Antigen (donor test) | Hepatitis B | Jul, 2010 | Negative | <2% chronic infections (USA), 33% past infections (worldwide) |
| Hepatitis B Virus Core Antibody (donor test) | Hepatitis B | Jul, 2010 | Negative | <2% chronic infections (USA), 33% past infections (worldwide) |
| Hepatitis C Virus Encoded Antibody and NAT (donor test) | Hepatitis C, HCV | Jul, 2010 | Negative | 1.6% |
| Rapid Plasma Reagin (RPR) Reflex to Fluorescent Treponemal Antibody (donor test) | Syphilis | Jul, 2010 | Non Reactive | 0.03% |
| Cytomegalovirus Total Antibody (donor test) (HCMV / Herpes Virus 5) | CMV | Jul, 2010 | Non Reactive | 50-90% (antibodies) |
| Human T-Cell Lymphotropic Virus I Antibody (donor test) | HTLV-1 | Jul, 2010 | Negative | 0-0.02% |
| Human T-Cell Lymphotropic Virus II Antibody (donor test) | HTLV-II | Jul, 2010 | Negative | 0-0.02% |
| Herpes Simplex Virus Type-1 (HSV-1) Antibody | Herpes (Cold Sores) | Jan, 2008 | Negative | 50-90% |
| Herpes Simplex Virus Type-2 (HSV-2) Antibody | Herpes (Genital) | Jan, 2008 | Negative | 18% (USA Males) |
| Physical Exam with visual observation for STDs by an M.D. | Physical | Dec, 2009 | Passed Exam |
Notes:
- HepA & Herpes test information is reported above for informational purposes. It cannot be spread by semen.
- Tests marked Donor Tests: This testing was performed by an FDA, and CLIA licensed laboratory that provides test kits that have been approved by the FDA for donor screening purpose only.
- The HIV-1 NAT test is a special test that shortens the window period between infection and detectability of disease to about 12 days
|
|
The FDA website describing approved Donor testing is:
- Testing HCT/P Donors: Specific Requirements:
http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/TissueSafety/ucm151757.htm
- Testing HCT/P Donors for Relevant Communicable Disease Agents and Diseases
http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/TissueSafety/ucm095440.htm
- Complete List of Donor Screening Assays for Infectious Agents and HIV Diagnostic Assays:
http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/ucm080466.htm
- Code of Federal Regulations Title 21
PART 1271 -- HUMAN CELLS, TISSUES, AND CELLULAR AND TISSUE-BASED PRODUCTS
Subpart C--Donor Eligibility Sec. 1271.85 What donor testing is required for different types of cells and tissues?https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=1271.85





